Cargando…

Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement

BACKGROUND: The use of transcatheter or surgical aortic valve replacement (AVR) for severe aortic stenosis (AS) has considerably increased in recent years. However, the association between AS etiology and mid-term clinical outcomes after surgical AVR has not been fully investigated. METHODS AND RESU...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Shiro, Inoue, Katsumi, Kumamaru, Hiraku, Yamashita, Takehiro, Hanyu, Michiya, Shirai, Shinichi, Ando, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064191/
https://www.ncbi.nlm.nih.gov/pubmed/32155164
http://dx.doi.org/10.1371/journal.pone.0229721
_version_ 1783504832775061504
author Miura, Shiro
Inoue, Katsumi
Kumamaru, Hiraku
Yamashita, Takehiro
Hanyu, Michiya
Shirai, Shinichi
Ando, Kenji
author_facet Miura, Shiro
Inoue, Katsumi
Kumamaru, Hiraku
Yamashita, Takehiro
Hanyu, Michiya
Shirai, Shinichi
Ando, Kenji
author_sort Miura, Shiro
collection PubMed
description BACKGROUND: The use of transcatheter or surgical aortic valve replacement (AVR) for severe aortic stenosis (AS) has considerably increased in recent years. However, the association between AS etiology and mid-term clinical outcomes after surgical AVR has not been fully investigated. METHODS AND RESULTS: We retrospectively included 201 patients (mean age, 75 years; 43%, men) who underwent surgical AVR for severe native AS (aortic valve area ≤1.0 cm(2) on preoperative transthoracic echocardiography examination). The following valve etiologies were postoperatively identified on pathological examination: post-inflammatory (n = 28), congenital (n = 35), and calcific/degenerative (n = 138). The median follow-up interval was 4.1 years following surgical AVR. Of the 201 patients, 27% were asymptomatic, 40% had a history of heart failure, and 11% underwent previous heart surgery. The cumulative incidence of cardiac events (all-cause death, aortic valve deterioration requiring repeated AVR, and hospitalization for heart failure) and combined adverse events, which included non-fatal stroke, unplanned coronary revascularization, pacemaker implantation, and gastrointestinal bleeding along with cardiac events, was significantly higher in the calcific/degenerative group (p = 0.02 and p = 0.02, respectively). In multivariate analysis adjusted for age, sex, renal function, heart failure, atrial fibrillation, concomitant surgical procedures, and EuroSCORE II, AS etiology was independently associated with an increased risk of combined adverse events (congenital vs. post-inflammatory: hazard ratio [HR], 4.13; p = 0.02 and calcific/degenerative vs. post-inflammatory: HR, 5.69; p = 0.002). CONCLUSIONS: Pathology-proven AS etiology could aid in predicting the mid-term outcomes after surgical AVR, supporting the importance of accurate identification of severe AS etiology with or without postoperative pathological examination.
format Online
Article
Text
id pubmed-7064191
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-70641912020-03-23 Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement Miura, Shiro Inoue, Katsumi Kumamaru, Hiraku Yamashita, Takehiro Hanyu, Michiya Shirai, Shinichi Ando, Kenji PLoS One Research Article BACKGROUND: The use of transcatheter or surgical aortic valve replacement (AVR) for severe aortic stenosis (AS) has considerably increased in recent years. However, the association between AS etiology and mid-term clinical outcomes after surgical AVR has not been fully investigated. METHODS AND RESULTS: We retrospectively included 201 patients (mean age, 75 years; 43%, men) who underwent surgical AVR for severe native AS (aortic valve area ≤1.0 cm(2) on preoperative transthoracic echocardiography examination). The following valve etiologies were postoperatively identified on pathological examination: post-inflammatory (n = 28), congenital (n = 35), and calcific/degenerative (n = 138). The median follow-up interval was 4.1 years following surgical AVR. Of the 201 patients, 27% were asymptomatic, 40% had a history of heart failure, and 11% underwent previous heart surgery. The cumulative incidence of cardiac events (all-cause death, aortic valve deterioration requiring repeated AVR, and hospitalization for heart failure) and combined adverse events, which included non-fatal stroke, unplanned coronary revascularization, pacemaker implantation, and gastrointestinal bleeding along with cardiac events, was significantly higher in the calcific/degenerative group (p = 0.02 and p = 0.02, respectively). In multivariate analysis adjusted for age, sex, renal function, heart failure, atrial fibrillation, concomitant surgical procedures, and EuroSCORE II, AS etiology was independently associated with an increased risk of combined adverse events (congenital vs. post-inflammatory: hazard ratio [HR], 4.13; p = 0.02 and calcific/degenerative vs. post-inflammatory: HR, 5.69; p = 0.002). CONCLUSIONS: Pathology-proven AS etiology could aid in predicting the mid-term outcomes after surgical AVR, supporting the importance of accurate identification of severe AS etiology with or without postoperative pathological examination. Public Library of Science 2020-03-10 /pmc/articles/PMC7064191/ /pubmed/32155164 http://dx.doi.org/10.1371/journal.pone.0229721 Text en © 2020 Miura et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Miura, Shiro
Inoue, Katsumi
Kumamaru, Hiraku
Yamashita, Takehiro
Hanyu, Michiya
Shirai, Shinichi
Ando, Kenji
Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement
title Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement
title_full Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement
title_fullStr Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement
title_full_unstemmed Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement
title_short Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement
title_sort clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064191/
https://www.ncbi.nlm.nih.gov/pubmed/32155164
http://dx.doi.org/10.1371/journal.pone.0229721
work_keys_str_mv AT miurashiro clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement
AT inouekatsumi clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement
AT kumamaruhiraku clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement
AT yamashitatakehiro clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement
AT hanyumichiya clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement
AT shiraishinichi clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement
AT andokenji clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement